CAS Medical Systems, Inc. CASMED of Branford, CT at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair
OEM

CAS Medical Systems, Inc. CASMED

44 E. Industrial Road, 06405 Branford, CT
USA

Telephone +1 203 285-4097
kmullins@casmed.com

This company is co-exhibitor of
U.S. Department of Commerce, U.S. Commercial Service

Hall map

MEDICA 2017 hall map (Hall 16): stand C04

Fairground map

MEDICA 2017 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.01  General Diagnostics

Our products

Product category: General Diagnostics

ADULT REGIONAL OXIMETRY

FORE-SIGHT sets the standard for cerebral oximetry with the most accurate and precise measure of oxygen levels in your patient’s brain. We provide reliable real-time information that empowers surgical teams to make informed intervention decisions throughout surgery. Superior sensor design, a patented algorithm, and an intuitive and easy-to-read interface set FORE-SIGHT apart from the rest of the marketplace.

More Less

Product category: General Diagnostics

NEONATAL & PEDIATRIC REGIONAL OXIMETRY

FORE-SIGHT, which raised the standard of tissue oximetry for adults, also provides the same high level of performance for pediatric and neonatal patients with the only sensors with a depth of light penetration that is tailored to accommodate anatomical differences between neonates, infants and children. Alternative manufacturers may market “pediatric” versions of their device, but with the exact same emitter-detector spacing and the same depth of penetration as their adult sensor – aren’t they really all the same? With FORE-SIGHT, you know you have the right sensor for your patient.

More Less

About us

Company details

WHEN CEREBRAL OXIMETRY TECHNOLOGY LAUNCHED commercially in 1993, it promised to provide insight into what some have referred to as the black box of the brain – by providing an objective assessment of the oxygenation of the brain.

While the first cerebral oximetry devices showed some promise, they failed to provide the level of accuracy and precision that was necessary to maximize their usefulness as a standard component of anesthesia management. This, coupled with design limitations of the initial devices led to a loss of confidence and relevance among some clinicians and early adopters, which may still remain today.

HOWEVER, CASMED CONTINUED TO BELIEVE in the promise and future of cerebral oximetry and continued to invest time and resources into developing, refining, enhancing, and validating the technology since 1999.

The first FORE-SIGHT monitor, launched in 2007, utilized four wavelengths of NIR light as opposed to two, generating exponentially better accuracy when compared to alternative devices. The current generation of FORE-SIGHT – FORESIGHT ELITE – now uses five wavelengths of light, along with additional design enhancements to ensure the most accurate readings on the market, allowing cerebral oximetry to finally be used as originally intended: a critical component of any anesthesia management protocol when used in the OR.

FORE-SIGHT PROVIDES ABSOLUTE, ACTIONABLE READINGS that detect cerebral desaturations so consistently and reliably that physicians are empowered to intervene or stay the course with confidence.

More Less